Small Cap New Lows: Momenta Pharmaceuticals (NASDAQ:MNTA), TriNet Group Inc (NYSE:TNET), Castlight Health Inc (NYSE:CSLT), Rally Software Development (NYSE:RALY)

Shares of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) dropped sharply after the U.S. Supreme Court agreed to hear an appeal from rival Teva Pharmaceutical, which is challenging Momenta’s plans to start selling a generic version of its drug, Copaxone. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) shares after opening at $11.17 moved to $11.31 on last trade day and at the end of the day closed at $11.25. Company price to sales ratio in past twelve months was calculated as 16.63 and price to cash ratio as 2.40. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) showed a negative weekly performance of -19.70%.

TriNet Group Inc. (NYSE: TNET), one of the largest professional employer organizations, commenced trading on the New York Stock Exchange last Thursday, with the initial public offering of 15,000,000 shares of common stock priced to the public at $16.00 per share. TriNet Group Inc (NYSE:TNET) shares fell -2.90% in last trading session and ended the day on $20.40.

Castlight Health Inc (NYSE:CSLT), a leading provider of enterprise healthcare cloud software, announced it has closed its previously announced initial public offering of 12,765,000 shares of its Class B common stock at a price to the public of $16.00 per share, which included 1,665,000 shares issued upon the exercise in full of the underwriters’ option to purchase additional shares. Castlight Health Inc (NYSE:CSLT) shares moved down -4.30% in last trading session and was closed at $21.57, while trading in range of $20.03-$22.97.Castlight Health Inc (NYSE:CSLT) year to date performance is -45.80%.

Shares of Rally Software Development Corp (NASDAQ:RALY) have received an average rating of “Buy” from the nine ratings firms that are presently covering the company, StockRatingsNetwork.com reports. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $33.00. Rally Software Development Corp (NYSE:RALY) weekly performance is -6.87%. On last trading day company shares ended up $12.75. Rally Software Development Corp (NYSE:RALY) distance from 50-day simple moving average is -34.15%. Analysts mean target price for the company is $30.00.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *